How Genomic Testing Helps Personalize Your Cancer Treatment

Because No Two Cancers—and No Two People—Are Exactly Alike

When you hear the word “cancer,” it may sound like a single diagnosis. But behind every case is something far more complex: your cancer’s unique genetic fingerprint.

Thanks to genomic testing, we now have a way to understand what makes your tumor different—and use that information to personalize your treatment plan.

Let’s walk through what that means and how PanTracer™ LBx, a simple blood test from NeoGenomics, is helping make it possible.

What Is Genomic Testing?

Genomic testing looks at the DNA of your tumor to find specific changes—called mutations—that may be driving its growth.

These changes aren’t inherited like the BRCA gene (that’s genetic testing). Instead, they happen inside the cancer itself. They’re like red flags that tell your care team more about how your cancer behaves.

And when doctors know what’s driving your cancer, they can choose treatments that target those changes directly.

How PanTracer LBx Makes It Easier

Traditionally, genomic testing required a tissue biopsy—meaning surgery or a needle procedure to remove part of your tumor.

But PanTracer LBx offers another option: a liquid biopsy, or a simple blood draw that looks for cancer DNA floating in your bloodstream.

This test uses next-generation sequencing (NGS) to scan for over 500 genes at once, giving your doctors powerful insights without needing another invasive procedure.

Why Personalization Matters in Cancer Care

Cancer treatment used to be more one-size-fits-all. Today, thanks to genomic testing, we can do better.

Here’s how a personalized approach helps:

• Targets your tumor’s specific mutations instead of general cancer types
• Reduces unnecessary treatments that may not work for your tumor
• Opens the door to clinical trials that match your tumor’s profile

It’s not about treating “breast cancer” or “lung cancer”—it’s about treating your cancer, your way.

What Makes PanTracer LBx Different?

• Minimally invasive: Just a blood draw—no surgery required
• Real-time tracking: Can be repeated to see how your cancer evolves
• Comprehensive: Tests for more than 500 genetic markers
• Fast and focused: Helps your care team act quickly and confidently
• Designed for advanced solid tumors like breast, colorectal, and lung cancer

Learn Look Locate: Helping You Understand the Power of Personalization

At Learn Look Locate, we believe that the more you understand your diagnosis, the more empowered you become in your care.

That’s why we’re honored to bring you this educational blog in collaboration with NeoGenomics, makers of the PanTracer™ Portfolio, including the PanTracer LBx blood test.

Genomic testing is changing the way cancer is treated. It helps turn fear into action and brings a sense of clarity in the middle of chaos. And with tools like PanTracer LBx, it’s never been easier to access these insights.

This is a sponsored blog post created in partnership with NeoGenomics.

Visit LearnLookLocate.com to explore medically reviewed resources that guide you with compassion, clarity, and confidence through every stage of your breast cancer journey.